Skip to main content

Table 4 CAS before and after GC therapy

From: Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy

  

Before GC therapy(n = 44)

After GC therapy(n = 54)

P*

CAS

Non-OHT eyes(n = 44)

3.86 ± 0.98

1.77 ± 0.91

0

OHT eyes(n = 54)

4.07 ± 0.95

1.98 ± 0.83

0

 

P

0.65

0.2

 
  1. Data represented as mean ± SD
  2. CAS Clinical activity score, GC Glucocorticoid, OHT Ocular hypertension
  3. P*:Before GC therapy vs after GC therapy
  4. P:Non-OHT eyes vs OHT eyes
  5. P and P*:Mann–Whitney U test
  6. P < 0.05 were considered statistically significant
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us